[Biotegy] Results of stabilization operations for the first five trading days following the company's listing
Biotegy announced that during its first five days of listing, the underwriter purchased 0 shares for price stabilization, indicating a strong market debut.
📋 Article Processing Timeline
- 📰 Published: April 16, 2026 at 09:00
- 🔍 Collected: April 17, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: April 18, 2026 at 23:53 (39h 52m after Collected)
1. Date of occurrence: 2026/04/16
2. Company name: Biotegy Corporation
3. Relationship with the company (enter this company or subsidiary): This company
4. Reciprocal shareholding ratio: Not applicable
5. Cause of occurrence:
In accordance with the guidelines of the Taiwan Securities Association for Underwriters Handling Initial Public Offerings, we hereby announce the results of the price stabilization operations for the first five trading days following the company's listing:
(1) Lead underwriter: Yuanta Securities Co., Ltd.
(2) Securities name and code: Biotegy (Stock code: 4169)
(3) Actual over-allotment quantity: 50,000 shares
(4) Underwriting price: NTD 102 per share
(5) Proceeds from over-allotment: NTD 5,100,000
(6) Execution period of stabilization operations: 2026/4/8~2026/4/14
(7) Cumulative quantity purchased by the lead underwriter's 'price stabilization account': 0 shares
6. Countermeasures: None
7. Other matters to be specified: None
2. Company name: Biotegy Corporation
3. Relationship with the company (enter this company or subsidiary): This company
4. Reciprocal shareholding ratio: Not applicable
5. Cause of occurrence:
In accordance with the guidelines of the Taiwan Securities Association for Underwriters Handling Initial Public Offerings, we hereby announce the results of the price stabilization operations for the first five trading days following the company's listing:
(1) Lead underwriter: Yuanta Securities Co., Ltd.
(2) Securities name and code: Biotegy (Stock code: 4169)
(3) Actual over-allotment quantity: 50,000 shares
(4) Underwriting price: NTD 102 per share
(5) Proceeds from over-allotment: NTD 5,100,000
(6) Execution period of stabilization operations: 2026/4/8~2026/4/14
(7) Cumulative quantity purchased by the lead underwriter's 'price stabilization account': 0 shares
6. Countermeasures: None
7. Other matters to be specified: None